fda bans compounded semaglutide The has received reports of adverse events after patients used versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved FDA and Novo Nordisk Warned

Double check this against your vial label

Propionate, produced by Akkermansia, has been shown to reduce activity in brain reward centers associated with high-calorie food cravings in human functional MRI studies

There are eight GLP-1R/GIPR/GCGR agonists under development in the world, of which, Rita's Retatrutide has made the fastest progress and launched the third phase clinical trial in June this year

PMID 37952131

In other words, your body might struggle to utilise the low-glycemic energy (i.e., high-fat, high-protein) energy youre suddenly relying on, and it may have a more challenging time accessing your body fat for fuel during activity